210 related articles for article (PubMed ID: 28051803)
1. Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).
Routhu M; Safka V; Routhu SK; Fejfar T; Jirkovsky V; Krajina A; Cermakova E; Hosak L; Hulek P
Ann Hepatol; 2017; 16(1):140-148. PubMed ID: 28051803
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
3. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients.
Yin X; Zhang F; Xiao J; Wang Y; He Q; Zhu H; Leng X; Zou X; Zhang M; Zhuge Y
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1264-1269. PubMed ID: 31136318
[TBL] [Abstract][Full Text] [Related]
5. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
Li Y; He X; Pang H
Turk J Gastroenterol; 2019 Aug; 30(8):702-707. PubMed ID: 31418414
[TBL] [Abstract][Full Text] [Related]
6. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
Deng D; Liao MS; Qin JP; Li XA
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
8. [Study on the comparative analysis of the efficacy of transmesenteric vein extrahepatic portosystemic shunt and transjugular intrahepatic portosystemic shunt in the treatment of cavernous transformation of portal vein].
Zhu YD; Li WX; Cui MZ; Wang H; Yang HP; Zhai ST
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):90-95. PubMed ID: 36948855
[No Abstract] [Full Text] [Related]
9. Bayesian network-based survival prediction model for patients having undergone post-transjugular intrahepatic portosystemic shunt for portal hypertension.
Chen R; Luo L; Zhang YZ; Liu Z; Liu AL; Zhang YW
World J Gastroenterol; 2024 Apr; 30(13):1859-1870. PubMed ID: 38659484
[TBL] [Abstract][Full Text] [Related]
10. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
[TBL] [Abstract][Full Text] [Related]
11. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Riggio O; Nardelli S; Moscucci F; Pasquale C; Ridola L; Merli M
Clin Liver Dis; 2012 Feb; 16(1):133-46. PubMed ID: 22321469
[TBL] [Abstract][Full Text] [Related]
12. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
Maleux G; Heye S; Verslype C; Nevens F
J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
[TBL] [Abstract][Full Text] [Related]
13. Parallel transjugular intrahepatic portosystemic shunt for controlling portal hypertension complications in cirrhotic patients.
He FL; Wang L; Yue ZD; Zhao HW; Liu FQ
World J Gastroenterol; 2014 Sep; 20(33):11835-9. PubMed ID: 25206289
[TBL] [Abstract][Full Text] [Related]
14. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
[TBL] [Abstract][Full Text] [Related]
15. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
16. Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients.
Jin YN; Zhang W
World J Gastroenterol; 2024 Apr; 30(16):2285-2286. PubMed ID: 38690019
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
18. Combined Spontaneous Portosystemic Shunt Embolization and Transjugular Intrahepatic Portosystemic Shunt Creation for Treatment of Hepatic Encephalopathy.
Gurtatta RS; Gaba RC; Herren JL
J Vasc Interv Radiol; 2024 May; 35(5):659-663. PubMed ID: 38355039
[TBL] [Abstract][Full Text] [Related]
19. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]